Ernexa Therapeutics Inc. Common Stock (ERNA)
Ernexa Therapeutics Inc. (ERNA) is a biotech company focused on developing innovative therapies for neurodegenerative diseases. The company leverages advanced technologies to identify and target novel pathways involved in conditions such as Alzheimer’s and Parkinson’s disease, aiming to address unmet medical needs in these areas.
Company News
Eterna Therapeutics to Present at ASGCT on Development of Beta 2 Microglobulin-Knockout (B2M-KO) iMSC Line
Insiders are buying these penny stocks in December. The post Penny Stocks To Buy: 3 Insider Picks For December 2022 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Gainers Huadi International Group Co., Ltd. (NASDAQ: HUDI) jumped 89.3% to close at $58.92 on Friday. Altamira Therapeutics Ltd. (NASDAQ: CYTO) climbed 58.6% to close at $0.5197 on Friday after the company announced divestiture of its inner ear development assets. Missfresh Limited (NASDAQ: MF) gained 57.5% to close at $2.52. Enservco Corporatio...